171 related articles for article (PubMed ID: 27389714)
1. Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study.
Zade PR; Gosavi SR; Hazarey VK; Ganvir SM
J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27389714
[TBL] [Abstract][Full Text] [Related]
2. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
[TBL] [Abstract][Full Text] [Related]
3. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
[TBL] [Abstract][Full Text] [Related]
4. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.
Lin SC; Chung MY; Huang JW; Shieh TM; Liu CJ; Chang KW
J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
6. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
[TBL] [Abstract][Full Text] [Related]
7. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
8. Roles of CYP1A1 and CYP2E1 Gene Polymorphisms in Oral Submucous Fibrosis.
Yaming P; Urs AB; Saxena A; Zuberi M
Asian Pac J Cancer Prev; 2016; 17(7):3335-40. PubMed ID: 27509973
[TBL] [Abstract][Full Text] [Related]
9. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
10. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Bharti AC; Jain S; Singh M
Biomarkers; 2010 Dec; 15(8):684-92. PubMed ID: 20860530
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
13. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Chaudhary AK; Pandya S; Mehrotra R; Singh M; Singh M
Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210
[TBL] [Abstract][Full Text] [Related]
14. The 5A Allele of the MMP3-Gene Promoter Polymorphism Is a Risk Factor for Poor Outcome of Hemodialysis Patients.
Dragovic JT; Popovic J; Djuric P; Bulatovic A; Jankovic A; Buzadzic I; Dimkovic N
Tohoku J Exp Med; 2017 Aug; 242(4):273-279. PubMed ID: 28781337
[TBL] [Abstract][Full Text] [Related]
15. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers.
Chang KW; Lee TC; Yeh WI; Chung MY; Liu CJ; Chi LY; Lin SC
Br J Cancer; 2004 Oct; 91(8):1551-5. PubMed ID: 15365571
[TBL] [Abstract][Full Text] [Related]
17. Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer.
Chiu CJ; Chiang CP; Chang ML; Chen HM; Hahn LJ; Hsieh LL; Kuo YS; Chen CJ
J Dent Res; 2001 Dec; 80(12):2055-9. PubMed ID: 11808761
[TBL] [Abstract][Full Text] [Related]
18. [Association of MMP3 promoter 5A/6A polymorphism with stability of extracellular matrix of atherosclerotic plaque].
Du J; Liu Y; Gao J; Chen S; Jiang H; Zhao L; Cong H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jun; 36(6):645-648. PubMed ID: 31055827
[TBL] [Abstract][Full Text] [Related]
19. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis.
Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q
Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779
[TBL] [Abstract][Full Text] [Related]
20. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
Chiu CJ; Chang ML; Chiang CP; Hahn LJ; Hsieh LL; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):646-53. PubMed ID: 12101112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
